| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CYSB2200288 | ACYW135群脑膜炎球菌多糖结合疫苗（CRM197载体） | Group ACYW135 Menningococcal Conjugate Vaccine | Injection | Biological Products(原6) | Supplementary Application | 2022-12-24 | CanSino Biologics Inc | view | |||
| CYSB2400306 | ACYW135群脑膜炎球菌多糖结合疫苗（CRM197载体） | Group ACYW135 Menningococcal Conjugate Vaccine | Injection | Biological Products(原6) | Supplementary Application | 2024-11-25 | CanSino Biologics Inc | view | |||
| CYSB2400154 | ACYW135群脑膜炎球菌多糖结合疫苗（CRM197载体） | Group ACYW135 Menningococcal Conjugate Vaccine | Injection | Biological Products(原6) | Supplementary Application | 2024-06-15 | CanSino Biologics Inc | view | |||
| CXSL2400066 | ACYW135群脑膜炎球菌多糖结合疫苗（CRM197载体） | Group ACYW135 Menningococcal Conjugate Vaccine | Injection | Biological Products(3.3) | New Drug Application | 2024-01-26 | Chengda Biology (Benxi) Co Ltd;Liaoning Chengda Biotechnology Co Ltd;Beijing Chengdatianhe Biotechnology Co Ltd | view | |||
| CYSB2400009 | ACYW135群脑膜炎球菌多糖结合疫苗（CRM197载体） | Group ACYW135 Menningococcal Conjugate Vaccine | Injection | Biological Products(原6) | Supplementary Application | 2024-01-09 | CanSino Biologics Inc | view |